The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Correlation between ribociclib resistance and circulating cytokines levels in metastatic breast cancer patients.
 
Ornella Garrone
Honoraria - Eisai; Novartis
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Eisai; Lilly; MSD; Seagen
 
Matteo Paccagnella
No Relationships to Disclose
 
Andrea Abbona
No Relationships to Disclose
 
Fiorella Ruatta
No Relationships to Disclose
 
Nerina Denaro
Speakers' Bureau - Bristol-Myers Squibb; MSD
 
Paola Vanella
No Relationships to Disclose
 
Gianluca Tomasello
No Relationships to Disclose
 
Donatella Gambini
No Relationships to Disclose
 
Giuseppe Aprile
Consulting or Advisory Role - Amgen; Baxter; Bristol-Myers Squibb/Celgene; Lilly; Merck; SERVIER
 
Massimo Di Maio
Honoraria - Astellas Pharma; AstraZeneca; Eisai; Janssen; MSD Oncology; Novartis; Pfizer; Roche; Takeda
Consulting or Advisory Role - Amgen; AstraZeneca; Eisai; Janssen; MSD Oncology; Novartis; Pfizer; Roche; Takeda
Research Funding - GlaxoSmithKline (Inst); Tesaro (Inst)
 
Marco Carlo Merlano
Consulting or Advisory Role - Nanobiotix
Speakers' Bureau - MSD
Research Funding - Merck Serono (Inst)